Noncutaneous neoplasms after kidney transplantation: analysis at single center.

[1]  N. Pallet,et al.  Clinical and immunological features of very long‐term survivors with a single renal transplant , 2012, Transplant international : official journal of the European Society for Organ Transplantation.

[2]  S. Saab,et al.  Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[3]  J. Grinyó,et al.  Malignancy after renal transplantation: the role of immunosuppression , 2010, Nature Reviews Nephrology.

[4]  J. Chapman,et al.  The KDIGO review of the care of renal transplant recipient. , 2010, Polskie Archiwum Medycyny Wewnetrznej.

[5]  J. Kaldor,et al.  Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study , 2010, BMJ : British Medical Journal.

[6]  D. Cranston,et al.  Urological malignancy after renal transplantation , 2007, BJU international.

[7]  A. Webster,et al.  Identifying High Risk Groups and Quantifying Absolute Risk of Cancer After Kidney Transplantation: A Cohort Study of 15 183 Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  J. Kaldor,et al.  Cancer incidence before and after kidney transplantation. , 2006, JAMA.

[9]  J. Fung,et al.  De novo malignancies after liver transplantation: A major cause of late death , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.